| Sign In to gain access to subscriptions and/or personal tools. |
Arterial Infusion of Combination Therapy Using Dibutyryl Adenosine 3' , 5' -Monophosphate and Mitomycin C for Hepatocellular Carcinoma Occluding Main Portal Vein: Case StudiesDepartment of Internal Medicine, School of Medicine, Kitasato University, Kitasato, Sagamihara, Japan
Department of Internal Medicine, School of Medicine, Kitasato University, Kitasato, Sagamihara, Japan
Department of Internal Medicine, School of Medicine, Kitasato University, Kitasato, Sagamihara, Japan
Department of Internal Medicine, School of Medicine, Kitasato University, Kitasato, Sagamihara, Japan
Intraarterial infusion therapy combining dibutyryl adenosine 3',5' monophosphate and mitomycin C was administered to 8 patients with hepato cellular carcinoma occluding the main portal vein. Three patients survived more than nine months, including 1 who has been well for forty-eight months with technical imaging showing complete regression. A decreased level of serum
Angiology, Vol. 40, No. 12,
1072-1078 (1989) |
|||
-fetoprotein of more than 90% was obtained in 38% of patients. Causes of death included hepatic failure, rupture of esophageal varices, acute gastric ul cer, and cerebral hemorrhage. It is concluded that the combination therapy may be useful for HCC.